Published in J Heart Lung Transplant on January 10, 2013
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Semin Respir Crit Care Med (2013) 0.98
Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant (2013) 0.93
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection. Trends Mol Med (2015) 0.90
Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection. Am J Transplant (2013) 0.85
Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms. Am J Transplant (2015) 0.82
Innate immune cells in transplantation. Curr Opin Organ Transplant (2014) 0.82
The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections. Inflammation (2016) 0.80
Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution. Int J Clin Exp Pathol (2014) 0.78
Update on Chronic Lung Allograft Dysfunction. Curr Transplant Rep (2016) 0.75
Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury. Curr Transplant Rep (2015) 0.75
Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003. Transplantation (2017) 0.75
Antibody-mediated Rejection in Lung Transplantation. Curr Transplant Rep (2015) 0.75
Influence of HLA Mismatching on Survival in Lung Transplantation. Lung (2015) 0.75
Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans. Lung (2016) 0.75
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant (2006) 2.81
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int (1993) 1.80
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77
Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation (2002) 1.56
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant (2003) 1.54
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation (2001) 1.44
Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant (2009) 1.34
Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant (2005) 1.24
Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant (2008) 1.05
C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant (2008) 1.01
C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant (2005) 1.01
Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant (1999) 1.00
C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol (2005) 1.00
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. J Heart Lung Transplant (2011) 0.90
Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant (2005) 0.90
Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation. Am J Transplant (2008) 0.87
Antibody-mediated rejection in lung transplantation: case reports. Clin Transpl (2006) 0.87
Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens (2005) 0.84
The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. Am J Surg Pathol (2012) 0.84
Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts. Transplantation (2008) 0.81
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest (2009) 2.96
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med (2003) 2.91
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2015) 2.80
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun (2006) 2.52
Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer (2006) 2.50
The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol (2004) 2.34
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32
Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24
Sirolimus-associated pulmonary toxicity. Transplantation (2004) 2.15
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. Hum Immunol (2007) 2.08
Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol (2002) 2.05
CXC chemokines in angiogenesis. Cytokine Growth Factor Rev (2005) 2.00
High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest (2007) 1.92
Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem (2007) 1.91
Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol (2006) 1.68
Cytokines in innate host defense in the lung. J Clin Invest (2002) 1.66
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2012) 1.66
CXCR2 is critical to hyperoxia-induced lung injury. J Immunol (2004) 1.65
CXC chemokines in angiogenesis of cancer. Semin Cancer Biol (2004) 1.65
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest (2005) 1.61
Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum (2006) 1.55
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer (2006) 1.54
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant (2003) 1.54
Optimizing HLA matching in a highly sensitized pediatric patient using ABO-incompatible and paired exchange kidney transplantation. Pediatr Nephrol (2015) 1.42
An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med (2011) 1.40
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med (2004) 1.40
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation (2005) 1.39
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol (2008) 1.33
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol (2008) 1.31
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol (2003) 1.29
Histopathology of pulmonary fibrotic disorders. Semin Respir Crit Care Med (2006) 1.26
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J Clin Invest (2014) 1.26
CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol (2005) 1.23
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann N Y Acad Sci (2004) 1.18
IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol (2007) 1.18
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol (2004) 1.16
Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol (2006) 1.12
CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest (2002) 1.11
HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol (2004) 1.09
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol (2005) 1.08
RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol (2007) 1.08
Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol (2002) 1.07
Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med (2007) 1.07
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med (2008) 1.07
Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics (2006) 1.07
Keratinocyte growth factor improves repair in the injured tracheal epithelium. Am J Respir Cell Mol Biol (2007) 1.06
CT Scan Segmental Airway Lumen Area. Chest (2015) 1.06
Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant (2009) 1.06
HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration. Sci Signal (2010) 1.06
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer (2004) 1.06
Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis (2003) 1.06
Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation (2005) 1.05
Pulmonary fibrosis. Methods Mol Med (2005) 1.04
Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation (2008) 1.04
Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum (2010) 1.04
Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med (2013) 1.04
HLA-B maternal-fetal genotype matching increases risk of schizophrenia. Am J Hum Genet (2006) 1.04
Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? Chest (2007) 1.03
Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res (2009) 1.02
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs. J Immunol (2013) 1.02
Kidney paired donation in the presence of donor-specific antibodies. Kidney Int (2013) 1.01
Subsequent infections in survivors of sepsis: epidemiology and outcomes. J Intensive Care Med (2012) 1.01
CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice. Pediatr Res (2005) 1.01
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med (2010) 1.01
C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant (2005) 1.01
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med (2011) 1.00
Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J Immunol (2002) 0.99
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Semin Respir Crit Care Med (2013) 0.98
Pulmonary arterial hypertension and lung transplantation. Semin Respir Crit Care Med (2010) 0.98
CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation (2006) 0.98
Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant (2009) 0.97
CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J Immunol (2006) 0.97
Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis. Cancer Prev Res (Phila) (2014) 0.96
The role of CXCR2/CXCR2 ligands in acute lung injury. Curr Drug Targets Inflamm Allergy (2005) 0.96